Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06707103 · ClinicalTrials.gov registry record · Phase 3
Tissue Repair Gel in Venous Leg Ulcers in AU/US
A Phase 3 study of Venous Leg Ulcer and Wound Heal, sponsored by TR Therapeutics.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 312
- Enrollment target
- 12
- Study locations
NCT06707103 is a Phase 3 study of Venous Leg Ulcer and Wound Heal that is actively recruiting participants, run by TR Therapeutics. The registered enrollment target is 312 participants, above the 236-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (32% higher). The trial reports 12 study locations across 7 states.
The verdict
NCT06707103, a Phase 3 study of Venous Leg Ulcer and Wound Heal, is actively recruiting participants, sponsored by TR Therapeutics.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 312 participants
- Enrollment target
- 12
- Study locations
Study Summary
The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.
Conditions Studied
Interventions
- OTHER Standard of care
- DRUG TR987 0.1% gel + Standard of Care
Study Locations (12)
New South Wales
- Clincial Research Site 62 - Camperdown
- Clinical Research Site 84 - Kogarah
- Clincial Research Site 78 - Orange
- Clincial Research Site 85 - Sydney
Victoria
- Clincial Research Site 74 - Bendigo
- Clincial Research Site 60 - Ivanhoe
- Clincial Research Site 65 - Shepparton
Florida
- Clincial Research Site 92 - Jacksonville
Michigan
- Clincial Research Site 77 - Clinton Twp
New York
- Clincial Research Site 82 - Lake Success
Texas
- Clinical Research Site 76 - Fort Worth
Western Australia
- Clincial Research Site 75 - Nedlands
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2025-04 |
| Est. Completion | 2027-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06707103
The ClinicalTrials.gov registry entry for NCT06707103 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 312 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 236-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (32% higher). The listed sponsor is TR Therapeutics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 8 conditions, with Venous Leg Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.
NCT06707103 reports 12 study locations spanning 7 distinct geographic areas - top geographies include New South Wales, Victoria, Florida.
Frequently Asked Questions
What is clinical trial NCT06707103 about?
NCT06707103 is a clinical study titled "Tissue Repair Gel in Venous Leg Ulcers in AU/US". The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.
What is the current status of trial NCT06707103?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 312 participants. The study started on 2025-04. Estimated completion is 2027-02.
What conditions does trial NCT06707103 study?
This clinical trial studies the following conditions: Venous Leg Ulcer, Wound Heal, Venous Ulcer, Wound, Venous Stasis.
What interventions are being tested in trial NCT06707103?
The interventions under investigation include: Standard of care (OTHER), TR987 0.1% gel + Standard of Care (DRUG).
Who is sponsoring clinical trial NCT06707103?
This trial is sponsored by TR Therapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06707103 being conducted?
This trial has 12 study locations across Florida, Michigan, New York, Texas, New South Wales. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Leg Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tissue Repair Gel in Venous Leg Ulcers (US)
RECRUITING · Phase 3
-
Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)
ACTIVE NOT RECRUITING · Phase 3
-
Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
COMPLETED · Phase 3
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.